Details of the Drug Reposition

General Information of This Drug (ID: DMLYP2N)

Drug Name
AMG 757   DMLYP2N
Drug Type
Antibody

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Neuroendocrine cancer DISVGJET 2B72.1 Phase 1 [1]
Small-cell lung cancer DISK3LZD 2C25.Y Phase 1 [2]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT04702737) A Study of AMG 757 in Participants With Neuroendocrine Prostate Cancer. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)